Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2023-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
独立董事对担保等事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion report from the independent directors of Huabang Life Health Co., Ltd. regarding various corporate governance and financial matters discussed at the 12th meeting of the 8th board of directors. It covers topics such as related party guarantees, fund occupation, profit distribution proposals, internal control self-assessment, goodwill impairment provision, and the reappointment of the audit firm. The document references compliance with laws, regulations, and company articles but does not contain full financial statements or detailed financial results. It is a governance-related opinion document rather than a full annual report, audit report, or earnings release. It is not a short announcement or certification but a detailed independent opinion on board matters. Therefore, it fits best under Board/Management Information (MANG), which includes announcements related to board activities and management opinions.
2023-04-26 Chinese
年度股东大会通知
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2022 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It includes details about the meeting date, voting procedures, agenda items such as the 2022 annual report and financial statements, and instructions for shareholders to participate. The document does not contain the actual annual report or financial statements but rather serves as an official announcement for the AGM and the related voting process. The document length is 4026 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits the category of AGM Information (AGM-R).
2023-04-26 Chinese
关于2022年度利润分配的预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2022 annual profit distribution plan of Huabang Life Health Co., Ltd. It includes details about the profit distribution proposal, legal compliance, audit results, and the approval process by the board and supervisory committee. The document does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). Instead, it focuses on the dividend distribution plan and related approvals, which aligns with a Notice of Dividend Amount (DIV). The document length is short (1445 characters), and it is not merely announcing the publication of a report but providing substantive information about the dividend plan itself.
2023-04-26 Chinese
独立董事2022年度述职报告（刘忠海）
Regulatory Filings
2023-04-26 Chinese
2022年年度审计报告
Regulatory Filings
2023-04-26 Chinese
年度关联方资金占用专项审计报告
Regulatory Filings
2023-04-26 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.